LOXL2 and glioblastoma: This is consistent with recent studies demonstrating the benefits of blocking collagen synthesis in a mouse model of GBM, where the blockage of the collagen crosslinking enzyme Lysyl oxidase homolog 2 enhanced chemotherapy efficacy in both murine and human patient‐derived xenograft GBM models [79].